| LM ID |
Analyte |
Treatment |
Time(hrs) |
Sample ID |
Value |
Units |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
0.0 |
BCD100322A002 |
0.87 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
0.5 |
BCD100322A005 |
0.97 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
1.0 |
BCD100322A009 |
0.69 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
2.0 |
BCD100322A013 |
1.72 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
4.0 |
BCD100322A017 |
1.87 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
8.0 |
BCD100322A021 |
1.45 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
12.0 |
BCD100322A025 |
1.93 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
24.0 |
BCD100322A029 |
4.75 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
0.0 |
BCD100322A001 |
0.77 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
0.5 |
BCD100322A003 |
0.88 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
1.0 |
BCD100322A007 |
0.95 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
2.0 |
BCD100322A011 |
0.81 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
4.0 |
BCD100322A015 |
1.09 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
8.0 |
BCD100322A019 |
0.95 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
12.0 |
BCD100322A023 |
2.16 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
24.0 |
BCD100322A027 |
3.18 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
0.5 |
BCD100322A006 |
1.13 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
1.0 |
BCD100322A010 |
0.61 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
2.0 |
BCD100322A014 |
1.36 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
4.0 |
BCD100322A018 |
1.91 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
8.0 |
BCD100322A022 |
1.23 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
12.0 |
BCD100322A026 |
1.19 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
24.0 |
BCD100322A030 |
2.01 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
0.5 |
BCD100322A004 |
0.36 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
1.0 |
BCD100322A008 |
0.6 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
2.0 |
BCD100322A012 |
0.48 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
4.0 |
BCD100322A016 |
1.69 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
8.0 |
BCD100322A020 |
0.55 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
12.0 |
BCD100322A024 |
1.28 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
24.0 |
BCD100322A028 |
1.95 |
pmol/ug DNA |